Related Experiment Video
Updated: Jul 13, 2026
A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 22, 2010
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7
A R La Spada1, Y H Fu, B L Sopher
1Department of Laboratory Medicine, University of Washington Medical Center, Seattle, WA 98195, USA. laspada@u.washington.edu
Abstract:
Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant disorder caused by a CAG repeat expansion. To determine the mechanism of neurotoxicity, we produced transgenic mice and observed a cone-rod dystrophy. Nuclear inclusions were present, suggesting that the disease pathway involves the nucleus. When yeast two-hybrid assays indicated that cone-rod homeobox protein (CRX) interacts with ataxin-7, we performed further studies to assess this interaction. We found that ataxin-7 and CRX colocalize and coimmunoprecipitate. We observed that polyglutamine-expanded ataxin-7 can dramatically suppress CRX transactivation. In SCA7 transgenic mice, electrophoretic mobility shift assays indicated reduced CRX binding activity, while RT-PCR analysis detected reductions in CRX-regulated genes. Our results suggest that CRX transcription interference accounts for the retinal degeneration in SCA7 and thus may provide an explanation for how cell-type specificity is achieved in this polyglutamine repeat disease.
Insights
Spinocerebellar ataxia type 7 (SCA7) causes retinal degeneration by interfering with the cone-rod homeobox protein (CRX). This polyglutamine disease mechanism involves nuclear inclusions and reduced gene regulation in affected cells.
Area of Science:
- Neuroscience
- Genetics
- Ophthalmology
Background:
- Spinocerebellar ataxia type 7 (SCA7) is an inherited neurodegenerative disorder.
- It is characterized by progressive loss of coordination and vision impairment.
- The disease results from a CAG repeat expansion in the ataxin-7 gene.
Purpose of the Study:
- To elucidate the neurotoxic mechanism underlying SCA7.
- To investigate the role of ataxin-7 and its interaction with cone-rod homeobox protein (CRX) in retinal degeneration.
Main Methods:
- Generation of SCA7 transgenic mouse models.
- Yeast two-hybrid assays to identify protein interactions.
- Co-immunoprecipitation and colocalization studies.
- Electrophoretic mobility shift assays (EMSA) and RT-PCR analysis.
Main Results:
- Transgenic mice exhibited cone-rod dystrophy, a form of retinal degeneration.
- Ataxin-7 was found to interact with CRX, colocalizing and coimmunoprecipitating.
- Polyglutamine-expanded ataxin-7 significantly suppressed CRX transactivation.
- Reduced CRX binding activity and decreased expression of CRX-regulated genes were observed in SCA7 mice.
Conclusions:
- CRX transcription interference is a key mechanism driving retinal degeneration in SCA7.
- This interaction provides insight into the cell-type specificity of SCA7 pathogenesis.
- Targeting the ataxin-7/CRX pathway may offer therapeutic strategies for SCA7.
